Market Watch (Free subscription) | 07/22/2008
Israeli stocks fell on Tuesday, snapping a three-session winning streak, with the banks and Teva Pharmaceutical leading the losers and Israel Chemicals rising for a second day after an analyst upgrade.
Israelated - English Israel blogs (Free subscription) | 07/22/2008
According to Haaretz, Teva has been going on a “little” shopping spree, buying companies as if they were cute pairs of shoes they just had to have. (And FYI, this Teva company has no connection to the Israeli hikers’ beloved Teva sandal co., incidentally made in China.) Recently, Teva purchased Barr Pharmaceuticals, “the fourth largest generic firm in the U.S., for $7.46 billion.” Teva had previously...
Market Watch (Free subscription) | 07/21/2008
Israel stocks rise strongly, helped by broker upgrades at Israel Chemicals and at Teva Pharmaceutical in the wake of its bid to acquire Barr Pharmaceuticals.
Market Watch (Free subscription) | 07/21/2008
LONDON (MarketWatch) -- Deutsche Bank upgraded Teva Pharmaceutical Industries to buy from hold, saying the group's plan to purchase Barr Pharmaceuticals Inc. for around $7.5 billion will enhance its growth prospects over the next four years. "Strategically, this transaction makes a lot of sense given little overlap in the two companies' businesses. First, Teva would benefit in the U.S. from an expanded...
Indy Star (Free subscription) | 07/19/2008
TRENTON, N.J. » Teva Pharmaceutical said Friday it will buy rival generic drug maker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drug maker.
Baltimore Sun (Free subscription) | 07/19/2008
Teva Pharmaceutical said yesterday that it would buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion.
Hispanic Business Magazine (Free subscription) | 07/18/2008
NEW YORK (Thomson Financial) - Teva Pharmaceutical Industries Ltd. Friday said it reached a definitive agreement to buy Barr Pharmaceuticals Inc. for a total consideration of $7.46 billion as well as the assumption of $1.5 billion in net debt....
Red Orbit (Free subscription) | 07/18/2008
Teva Pharmaceutical Industries Ltd. of Israel said Friday it had agreed to purchase Barr Pharmaceuticals Inc., in a deal valued at $8.96 billion.
USA Today (Free subscription) | 07/18/2008
Israeli drugmaker Teva Pharmaceutical said Friday it will buy rival generic drug company Barr Pharmaceuticals for more than $7 ...
MSNBC.com (Free subscription) | 07/18/2008
Israeli drugmaker Teva Pharmaceutical said it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion.
International Herald Tribune (Free subscription) | 07/18/2008
The Israeli drugmaker Teva Pharmaceutical said Friday it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion in a move to expand its presence in U.S. and Eastern European markets.
atHome Top Story (Free subscription) | 07/18/2008
Israeli drug-maker Teva Pharmaceutical said Friday it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion (U.S.) in a move to expand its presence in U.S. and Eastern European markets.
FT.com - Europe homepage (Free subscription) | 07/18/2008
Teva, the Israeli generic drugs group, is to acquire Barr of the US in a $7.5bn deal that will strongly reinforce its position as the world's largest seller of off-patent medicines
Market Watch (Free subscription) | 07/18/2008
Teva Pharmaceutical agrees to buy smaller generics rival Barr Pharmaceuticals Ifor $7.46 billion plus about $1.5 billion in assumed debt.
Seattle Times (Free subscription) | 07/18/2008
Israeli drugmaker Teva Pharmaceutical said Friday it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion in a move to expand its presence in U.S. and Eastern European markets.
